Investors were warned last week about problems with Cell Therapeutics's cancer drug pixantrone.
twocents@thestreet.com (Adam Feuerstein ), The Street
Mon, 02/08/2010 - 10:29am
Investors were warned last week about problems with Cell Therapeutics's cancer drug pixantrone.